News - Germany

Filter

Current filters:

Germany

Popular Filters

1 to 25 of 59 results

Executive Q&A: Thomas Hein, SVP commercial and regulatory affairs, Hermes Pharma

Executive Q&A: Thomas Hein, SVP commercial and regulatory affairs, Hermes Pharma

28-07-2014

In an interview with The Pharma Letter, Thomas Hein, senior vice president of commercial and regulatory…

Dosage formsDrug DeliveryGermanyHermes PharmaInterviewsPharmaceutical

Zealand and Boehringer link up to advance novel peptide medicines

Zealand and Boehringer link up to advance novel peptide medicines

28-07-2014

Denmark’s Zealand Pharma has entered into a new global exclusive licence and R&D collaboration with…

Boehringer IngelheimCardio-vascularDenmarkFinancialGermanyLicensingMetabolicsPharmaceuticalResearchZealand Pharma

BMJ alleges Boehringer Ingelheim withheld Pradaxa dosing information from regulators

BMJ alleges Boehringer Ingelheim withheld Pradaxa dosing information from regulators

24-07-2014

German family-owned drug major Boehringer Ingelheim has been accused of withholding ‘important analyses’…

Boehringer IngelheimDabigatranGermanyHematologyPharmaceuticalPradaxaPyridinesRegulationUKUniversity of California

Malini Moorthy joins Bayer as head of litigation

Malini Moorthy joins Bayer as head of litigation

16-07-2014

Bayer Corporation, a US subsidiary of German drug major Bayer has hired Malini Moorthy as head of its…

BayerBayer CorporationBoardroomEconomy of GermanyGermanyHead of the litigation departmentIG FarbenMalini MoorthyPharmaceuticalUSA

Breast cancer: DMP is largely consistent with guidelines, says IQWiG

Breast cancer: DMP is largely consistent with guidelines, says IQWiG

16-07-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) has today published the results…

Breast cancerGermanyInstitute for Quality and Efficiency in Health CareOncologyPharmaceuticalRegulation

CellAct Pharma receives orphan drug designation in EU for cancer drug

CellAct Pharma receives orphan drug designation in EU for cancer drug

16-07-2014

The European Medicines Agency’s Committee for Orphan Medicinal Products has granted German cancer specialists…

CAP7.1CellAct PharmaEuropeGermanyHepatologyOncologyPharmaceuticalRegulationTreatment of biliary tract cancers

Final funding boost for immatics to complete Phase III study

Final funding boost for immatics to complete Phase III study

16-07-2014

Germany’s privately-held immatics biotechnologies GmbH has received 22 million euros ($29 million)…

BiotechnologyFinancialGermanyimmatics biotechnologiesOncologyRenal cell carcinomaResearchSutent

Russian firm R-Pharm acquires Pfizer’s German plant

Russian firm R-Pharm acquires Pfizer’s German plant

04-07-2014

R-Pharm, one of Russia’s largest pharmaceutical producers, is expanding in the European Union market…

GermanyPharmaceuticalProductionRussia

NicOx launches commercial operations in Germany

30-06-2014

Ophthalmology-focused French biotech firm NicOx has today announced the launch of its German operations.

AdenoPlusBiotechnologyGermanyManagementMarkets & MarketingNicOxOphthalmicsXailin

Added benefit of Invokana in type 2 diabetes is not proven, says IQWiG

Added benefit of Invokana in type 2 diabetes is not proven, says IQWiG

17-06-2014

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

DiabetesGermanyInvokanaJanssen-CilagJohnson & JohnsonPharmaceuticalPricingRegulation

CMO Rentschler expands single-use manufacturing capacities

06-06-2014

German contract manufacturing organization (CMO) Rentschler Biotechnologie has announced the addition…

BiotechnologyGermanyProductionRentschler Biotechnologie

Stada will continue to develop emerging markets as domestic growth drops

Stada will continue to develop emerging markets as domestic growth drops

05-06-2014

German generic and branded drugmaker Stada Arzneimittel’s executive board chairman, Hartmut Retzlaff,…

Business FinanceBusiness FinanceFinancialGenericsGermanyPharmaceuticalSTADA ArzneimittelSTADA Pharmaceuticals

Boehringer resolves FDA manufacturing facility concerns

Boehringer resolves FDA manufacturing facility concerns

03-06-2014

German family-owned pharma major Boehringer Ingelheim said today that it has been notified by a letter…

Boehringer IngelheimFood and Drug AdministrationGermanyPharmaceuticalPharmaceutical sciencesProductionRegulationResearchUSA

EMA “look, but don’t touch” terms of use for clinical study data are impracticable, says IQWiG

EMA “look, but don’t touch” terms of use for clinical study data are impracticable, says IQWiG

28-05-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) has taken issue with plans announced…

EuropeGermanyPharmaceuticalRegulationResearch

Executive Q&A: Paul Higham, CEO of immatics

Executive Q&A: Paul Higham, CEO of immatics

27-05-2014

In an interview with The Pharma Letter, immatics chief executive Paul Higham discusses the company's…

BiotechnologyCancerGermanyHealth Medical Pharmaimmatics biotechnologiesImmunologyInterviewsMedicineOncologyVaccination

IQWIG finds added benefit in adult patients for VIIV Healthcare’s Tivicay

27-05-2014

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products (AMNOG),…

Anti-viralsGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationTivicayViiV Healthcare

Negative IQWiG view on AstraZeneca’s combo diabetes drug Xigduo

16-05-2014

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

AstraZenecaDiabetesGermanyPharmaceuticalPricingRegulationXigduo

Proteros announces changes in management team

Proteros announces changes in management team

12-05-2014

German biotech company Proteros has announced significant changes in its management team.

BiotechnologyBoardroomGermanyProteros

Merck appoints Wolfgang Büchele as Supervisory Board Chairman

Merck appoints Wolfgang Büchele as Supervisory Board Chairman

12-05-2014

The Supervisory Board of Merck has elected Wolfgang Büchele as Chairman of its corporate governance…

BoardroomGermanyMerck KGaAPharmaceutical

Eisai expands deal with Biogen; re-files Fycompa with G-BA; news on Zebinix

Eisai expands deal with Biogen; re-files Fycompa with G-BA; news on Zebinix

12-05-2014

Japanese drug major Eisai has exercised its option to jointly develop and commercialize its clinical…

Biogen IdecEisaiFycompaGermanyItalyLicensingNeurologicalPharmaceuticalPricingRegulationZebinix

1 to 25 of 59 results

Back to top